Trial Summary
What is the purpose of this trial?Conduct a study of people who use drugs (PWUD) perceptions of and access to COVID-19 vaccines as well as reasons for vaccine hesitancy/barriers
Eligibility Criteria
This trial is for people who have used opioids in the last two weeks. It's focused on understanding their views on COVID-19 vaccines, access to these vaccines, and what might be stopping them from getting vaccinated. There are no specific exclusion criteria listed.Treatment Details
The study isn't testing a new drug or treatment. Instead, it's analyzing how people who inject drugs feel about COVID-19 vaccines and identifying any obstacles they face in getting vaccinated.
1Treatment groups
Experimental Treatment
Group I: ExperimentalExperimental Treatment1 Intervention
behavioral intervention
Find a clinic near you
Research locations nearbySelect from list below to view details:
Johns Hopkins Bloomberg School of Public HealthBaltimore, MD
Loading ...
Who is running the clinical trial?
Johns Hopkins Bloomberg School of Public HealthLead Sponsor
National Institutes of Health (NIH)Collaborator